79 related articles for article (PubMed ID: 17530883)
1. Structure-activity relationships of alphaS1-casomorphin using AM1 calculations and molecular dynamics simulations.
Wu YC; Lin JS; Hwang CC
J Phys Chem B; 2007 Jun; 111(25):7377-83. PubMed ID: 17530883
[TBL] [Abstract][Full Text] [Related]
2. A three-dimensional model of the delta-opioid pharmacophore: comparative molecular modeling of peptide and nonpeptide ligands.
Shenderovich MD; Liao S; Qian X; Hruby VJ
Biopolymers; 2000 Jun; 53(7):565-80. PubMed ID: 10766952
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships of Leu-Enkephalin analog with (4-Carboxamido)phenylalanine substituted for tyrosine: a molecular dynamics study.
Wang YC; Wu YC; Yeh CC; Hwang CC
Biopolymers; 2007 Jun; 86(3):231-9. PubMed ID: 17377963
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of modified C-terminal endomorphin-2 analogues by molecular dynamics simulations.
Wang YC; Wu YC; Chen JW; Huang LS; Tsai FR; Hwang CC
J Mol Graph Model; 2008 Nov; 27(4):489-96. PubMed ID: 18930674
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel opioid peptide (Tyr-Val-Pro-Phe-Pro) derived from human alpha S1 casein (alpha S1-casomorphin, and alpha S1-casomorphin amide).
Kampa M; Loukas S; Hatzoglou A; Martin P; Martin PM; Castanas E
Biochem J; 1996 Nov; 319 ( Pt 3)(Pt 3):903-8. PubMed ID: 8920997
[TBL] [Abstract][Full Text] [Related]
6. Four-component pharmacophore model for endomorphins toward μ opioid receptor subtypes.
Wu YC; Jaglinski T; Hsieh JY; Chiu JJ; Chiang TY; Hwang CC
J Mol Model; 2012 Feb; 18(2):825-34. PubMed ID: 21618021
[TBL] [Abstract][Full Text] [Related]
7. 2D conformationally sampled pharmacophore: a ligand-based pharmacophore to differentiate delta opioid agonists from antagonists.
Bernard D; Coop A; MacKerell AD
J Am Chem Soc; 2003 Mar; 125(10):3101-7. PubMed ID: 12617677
[TBL] [Abstract][Full Text] [Related]
8. Opioid alkaloids and casomorphin peptides decrease the proliferation of prostatic cancer cell lines (LNCaP, PC3 and DU145) through a partial interaction with opioid receptors.
Kampa M; Bakogeorgou E; Hatzoglou A; Damianaki A; Martin PM; Castanas E
Eur J Pharmacol; 1997 Sep; 335(2-3):255-65. PubMed ID: 9369381
[TBL] [Abstract][Full Text] [Related]
9. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
[TBL] [Abstract][Full Text] [Related]
10. New benzomorphan derivatives of MPCB as MOP and KOP receptor ligands.
Pasquinucci L; Iadanza M; Marrazzo A; Prezzavento O; Ronsisvalle S; Scoto GM; Parenti C; De Luca L; Ronsisvalle G
Pharmazie; 2007 Nov; 62(11):813-24. PubMed ID: 18065096
[TBL] [Abstract][Full Text] [Related]
11. Incorporating receptor flexibility in the molecular design of protein interfaces.
Li L; Liang S; Pilcher MM; Meroueh SO
Protein Eng Des Sel; 2009 Sep; 22(9):575-86. PubMed ID: 19643976
[TBL] [Abstract][Full Text] [Related]
12. Exploring structure and dynamics of the diaquotriamminezinc(II) complex by QM/MM MD simulation.
Fatmi MQ; Hofer TS; Randolf BR; Rode BM
J Phys Chem B; 2008 May; 112(18):5788-94. PubMed ID: 18447349
[TBL] [Abstract][Full Text] [Related]
13. Conformational stability from variable temperature FT-IR spectra of krypton solutions, r0 structural parameters, vibrational assignment, and ab initio calculations of 4-fluoro-1-butene.
Guirgis GA; Yu Z; Zheng C; Zhou SX; Durig JR
J Phys Chem A; 2008 Mar; 112(11):2268-81. PubMed ID: 18298100
[TBL] [Abstract][Full Text] [Related]
14. Solvation shell structure of cyclooctylpyranone in water solvent and its comparative structure, dynamics and dipole moment in HIV protease.
Arul Murugan N; Chandra Jha P; Agren H
Phys Chem Chem Phys; 2009 Aug; 11(30):6482-9. PubMed ID: 19809680
[TBL] [Abstract][Full Text] [Related]
15. Nascent structure-activity relationship study of a diastereomeric series of kappa opioid receptor antagonists derived from CJ-15,208.
Dolle RE; Michaut M; Martinez-Teipel B; Seida PR; Ajello CW; Muller AL; DeHaven RN; Carroll PJ
Bioorg Med Chem Lett; 2009 Jul; 19(13):3647-50. PubMed ID: 19464172
[TBL] [Abstract][Full Text] [Related]
16. Ultrafast dynamics of hydrogen bond exchange in aqueous ionic solutions.
Park S; Odelius M; Gaffney KJ
J Phys Chem B; 2009 Jun; 113(22):7825-35. PubMed ID: 19435307
[TBL] [Abstract][Full Text] [Related]
17. Fast screening and quantitative evaluation of internally deleted goat alphas1-casein variants by mass spectrometric detection of the signature peptides.
Picariello G; Ferranti P; Caira S; Fierro O; Chianese L; Addeo F
Rapid Commun Mass Spectrom; 2009 Mar; 23(6):775-87. PubMed ID: 19219844
[TBL] [Abstract][Full Text] [Related]
18. Beta-hairpin folding by a model amyloid peptide in solution and at an interface.
Knecht V
J Phys Chem B; 2008 Aug; 112(31):9476-83. PubMed ID: 18593146
[TBL] [Abstract][Full Text] [Related]
19. Steric zipper of the amyloid fibrils formed by residues 109-122 of the Syrian hamster prion protein.
Lee SW; Mou Y; Lin SY; Chou FC; Tseng WH; Chen CH; Lu CY; Yu SS; Chan JC
J Mol Biol; 2008 May; 378(5):1142-54. PubMed ID: 18423487
[TBL] [Abstract][Full Text] [Related]
20. Structure-function relationship of inhibitory Smads: Structural flexibility contributes to functional divergence.
Hariharan R; Pillai MR
Proteins; 2008 Jun; 71(4):1853-62. PubMed ID: 18175316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
